45 related articles for article (PubMed ID: 17604167)
1. Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using Positron Emission Tomography in rat and non-human primate.
Purohit A; Benetti R; Hayes M; Guaraldi M; Kagan M; Yalamanchilli P; Su F; Azure M; Mistry M; Yu M; Robinson S; Dischino DD; Casebier D
Bioorg Med Chem Lett; 2007 Sep; 17(17):4882-5. PubMed ID: 17604167
[TBL] [Abstract][Full Text] [Related]
2. Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.
Yu M; Guaraldi M; Kagan M; Mistry M; McDonald J; Bozek J; Yalamanchili P; Hayes M; Azure M; Purohit A; Radeke H; Casebier DS; Robinson SP
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):63-72. PubMed ID: 18716773
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of the mitochondrial complex 1 inhibitor 2-[4-(4-fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one as a potential cardiac positron emission tomography tracer.
Radeke H; Hanson K; Yalamanchili P; Hayes M; Zhang ZQ; Azure M; Yu M; Guaraldi M; Kagan M; Robinson S; Casebier D
J Med Chem; 2007 Sep; 50(18):4304-15. PubMed ID: 17696417
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of [¹⁸F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography.
Kim DY; Kim HJ; Yu KH; Min JJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):319-22. PubMed ID: 22133630
[TBL] [Abstract][Full Text] [Related]
6. Impact of physicochemical and structural properties on the pharmacokinetics of a series of alpha1L-adrenoceptor antagonists.
Betts A; Atkinson F; Gardner I; Fox D; Webster R; Beaumont K; Morgan P
Drug Metab Dispos; 2007 Aug; 35(8):1435-45. PubMed ID: 17502340
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers.
Purohit A; Radeke H; Azure M; Hanson K; Benetti R; Su F; Yalamanchili P; Yu M; Hayes M; Guaraldi M; Kagan M; Robinson S; Casebier D
J Med Chem; 2008 May; 51(10):2954-70. PubMed ID: 18422306
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
9. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography.
Zhang Y; Thorn S; DaSilva JN; Lamoureux M; DeKemp RA; Beanlands RS; Ruel M; Suuronen EJ
Circ Cardiovasc Imaging; 2008 Nov; 1(3):197-204. PubMed ID: 19808543
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET.
Shoup TM; Elmaleh DR; Brownell AL; Zhu A; Guerrero JL; Fischman AJ
Mol Imaging Biol; 2011 Jun; 13(3):511-517. PubMed ID: 20563755
[TBL] [Abstract][Full Text] [Related]
13. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
Yanamoto K; Kumata K; Yamasaki T; Odawara C; Kawamura K; Yui J; Hatori A; Suzuki K; Zhang MR
Bioorg Med Chem Lett; 2009 Mar; 19(6):1707-10. PubMed ID: 19217778
[TBL] [Abstract][Full Text] [Related]
14. New fluoro-diphenylchalcogen derivatives to explore the serotonin transporter by PET.
Vercouillie J; Deuther-Conrad W; Scheunemann M; Emond P; Fischer S; Funke U; Steinbach J; Guilloteau D; Brust P
Bioorg Med Chem Lett; 2007 Sep; 17(17):4991-5. PubMed ID: 17658253
[TBL] [Abstract][Full Text] [Related]
15. Detection of ischemic neuronal damage with [¹⁸F]BMS-747158-02, a mitochondrial complex-1 positron emission tomography ligand: small animal PET study in rat brain.
Fukumoto D; Nishiyama S; Harada N; Yamamoto S; Tsukada H
Synapse; 2012 Oct; 66(10):909-17. PubMed ID: 22807129
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
[TBL] [Abstract][Full Text] [Related]
17. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
Demirkol MO
Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model.
Nekolla SG; Reder S; Saraste A; Higuchi T; Dzewas G; Preissel A; Huisman M; Poethko T; Schuster T; Yu M; Robinson S; Casebier D; Henke J; Wester HJ; Schwaiger M
Circulation; 2009 May; 119(17):2333-42. PubMed ID: 19380625
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.
Iino T; Sasaki Y; Bamba M; Mitsuya M; Ohno A; Kamata K; Hosaka H; Maruki H; Futamura M; Yoshimoto R; Ohyama S; Sasaki K; Chiba M; Ohtake N; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem Lett; 2009 Oct; 19(19):5531-8. PubMed ID: 19726182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
